MICROCHIP TECHNOLOGY INCORPORATED (MCHP) FY2025 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-04-01 to 2025-03-31

Swipe to see the full flow
MICROCHIP TECHNOLOGY INCORPORATED cash flow reconciliation, Apr 1, 2024 through Mar 31, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Depreciation and amortization → operating reconciliation: $750,100,000.00Decrease (increase) in accounts receivable → operating reconciliation: $454,000,000.00Share-based compensation expense related to equity incentive plans → operating reconciliation: $180,400,000.00Amortization of debt discount → operating reconciliation: $64,800,000.00Decrease (increase) in inventories → operating reconciliation: $31,600,000.00Amortization of debt issuance costs → operating reconciliation: $7,800,000.00Loss on settlement of debt → operating reconciliation: $1,700,000.00operating reconciliation → Net cash from operating activities: $898,100,000.00operating reconciliation → Net (loss) income: $500,000.00operating reconciliation → (Decrease) increase in accounts payable and accrued liabilities: $345,600,000.00operating reconciliation → Deferred income taxes: $143,300,000.00operating reconciliation → Other: $63,000,000.00operating reconciliation → Change in other assets and liabilities: $38,100,000.00operating reconciliation → Change in income tax payable: $1,800,000.00Other investing → investing reconciliation: $2,400,000.00Proceeds from capital-related government incentives → investing reconciliation: $400,000.00investing reconciliation → Investments in other assets: $164,600,000.00investing reconciliation → Capital expenditures: $126,000,000.00Net cash used in financing activities → financing reconciliation: $158,300,000.00Proceeds from issuance of Commercial Paper → financing reconciliation: $13,937,500,000.00Proceeds from issuance of senior notes → financing reconciliation: $1,992,200,000.00Issuance of Series A Preferred Stock → financing reconciliation: $1,449,500,000.00Proceeds from issuance of convertible debt → financing reconciliation: $1,250,000,000.00Proceeds from borrowings on Revolving Credit Facility → financing reconciliation: $68,000,000.00Proceeds from sale of common stock → financing reconciliation: $65,400,000.00financing reconciliation → Repayments of Commercial Paper: $15,113,900,000.00financing reconciliation → Repayment of senior notes: $1,000,000,000.00financing reconciliation → Payment of cash dividends: $975,700,000.00financing reconciliation → Repayments of 2025 Term Loan Facility: $750,000,000.00financing reconciliation → Payments on settlement of convertible debt: $672,200,000.00financing reconciliation → Purchase of capped call options: $160,100,000.00financing reconciliation → Repurchase of common stock: $96,500,000.00financing reconciliation → Proceeds from borrowings on Revolving Credit Facility: $68,000,000.00financing reconciliation → Tax payments related to shares withheld for vested RSUs: $57,600,000.00financing reconciliation → Deferred financing costs: $19,700,000.00financing reconciliation → Other Financing: $5,600,000.00financing reconciliation → Capital lease payments: $1,600,000.00Net cash used in investing activities → investing reconciliation: $287,800,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $319,700,000.00Net cash from operating activities → Cash sources and uses: $898,100,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $771,700,000.00Cash sources and uses → Net cash used in investing activities: $287,800,000.00Cash sources and uses → Net cash used in financing activities: $158,300,000.00Loss on settlement of debt: $1,700,000.00Debt extinguishment gain & loss+$1.70 MNet (loss) income: -$500,000.00Net (loss) income−$500.00 KAmortization of debt discount: $64,800,000.00Discount & premium amortization+$64.80 MAmortization of debt issuance costs: $7,800,000.00Debt issuance cost amortization+$7.80 MDeferred income taxes: -$143,300,000.00Deferred income taxes−$143.30 MOther: -$63,000,000.00Other operating, net−$63.00 MDepreciation and amortization: $750,100,000.00Depreciation & amortization+$750.10 MShare-based compensation expense related to equity incentive plans: $180,400,000.00Stock-based compensation+$180.40 MImpairment of intangible assets: $0.00Decrease (increase) in accounts receivable: $454,000,000.00Accounts receivable+$454.00 MDecrease (increase) in inventories: $31,600,000.00Inventories+$31.60 M(Decrease) increase in accounts payable and accrued liabilities: -$345,600,000.00Payables & accrued liabilities−$345.60 MChange in other assets and liabilities: -$38,100,000.00Other working capital, net−$38.10 MChange in income tax payable: -$1,800,000.00Income taxes payable−$1.80 MNet cash from operating activities: $898,100,000.00Operating cash+$898.10 Moperating reconciliation: $1,490,400,000.00Proceeds from borrowings on Revolving Credit Facility: $68,000,000.00Credit line borrowings+$68.00 MProceeds from sale of common stock: $65,400,000.00Common stock issued+$65.40 MRepurchase of common stock: -$96,500,000.00Common stock repurchases−$96.50 MProceeds from borrowings on Revolving Credit Facility: -$68,000,000.00Credit line repayments−$68.00 MProceeds from issuance of Commercial Paper: $13,937,500,000.00Commercial paper issued+$13.94 BRepayment of senior notes: -$1,000,000,000.00Senior debt repaid−$1.00 BRepayments of Commercial Paper: -$15,113,900,000.00Commercial paper repaid−$15.11 BPayments on settlement of convertible debt: -$672,200,000.00Convertible debt repaid−$672.20 MCapital lease payments: -$1,600,000.00Finance lease payments−$1.60 MTax payments related to shares withheld for vested RSUs: -$57,600,000.00Stock-award tax withholding−$57.60 MPayment of cash dividends: -$975,700,000.00Ordinary dividends paid−$975.70 MProceeds from issuance of convertible debt: $1,250,000,000.00Convertible debt issued+$1.25 BDeferred financing costs: -$19,700,000.00Financing costs paid−$19.70 MPurchase of capped call options: -$160,100,000.00Capped call purchases−$160.10 MProceeds from borrowings on 2025 Term Loan Facility: $0.00Proceeds from issuance of senior notes: $1,992,200,000.00Senior debt issued+$1.99 BOther Financing: -$5,600,000.00Other financing, net−$5.60 MRepayments of 2025 Term Loan Facility: -$750,000,000.00Other long-term debt repaid−$750.00 MIssuance of Series A Preferred Stock: $1,449,500,000.00Convertible preferred issued+$1.45 BNet cash used in financing activities: -$158,300,000.00. Cash required to fund net payments.Financing cash−$158.30 Mfinancing reconciliation: $18,920,900,000.00Capital expenditures: -$126,000,000.00PP&E purchases−$126.00 MInvestments in other assets: -$164,600,000.00Other capital spending−$164.60 MProceeds from capital-related government incentives: $400,000.00Capital incentives received+$400.00 KOther investing: $2,400,000.00Other investing, net+$2.40 MNet cash used in investing activities: -$287,800,000.00. Cash required to fund net payments.Investing cash−$287.80 Minvesting reconciliation: $290,600,000.00Cash sources and uses: $1,217,800,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $319,700,000.00Beginning cash$319.70 MEnding cash: Cash, cash equivalents, and restricted cash: $771,700,000.00Ending cash$771.70 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsNet loss −$500.00K + net operating adjustments $898.60M = operating cash +$898.10MFree cash flow$772.10 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$452.00 MEnding cash − beginning cash
Chart details

MICROCHIP TECHNOLOGY INCORPORATED cash flow reconciliation, Apr 1, 2024 through Mar 31, 2025

Cash flows for Apr 1, 2024 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2024
319,700,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
898,100,000 US dollars. Net cash provided.
Net (loss) income
negative 500,000 US dollars
Loss on settlement of debt
1,700,000 US dollars
Amortization of debt discount
64,800,000 US dollars
Amortization of debt issuance costs
7,800,000 US dollars
Deferred income taxes
negative 143,300,000 US dollars
Other
negative 63,000,000 US dollars
Depreciation and amortization
750,100,000 US dollars
Share-based compensation expense related to equity incentive plans
180,400,000 US dollars
Impairment of intangible assets
0 US dollars
Decrease (increase) in accounts receivable
454,000,000 US dollars
Decrease (increase) in inventories
31,600,000 US dollars
(Decrease) increase in accounts payable and accrued liabilities
negative 345,600,000 US dollars
Change in other assets and liabilities
negative 38,100,000 US dollars
Change in income tax payable
negative 1,800,000 US dollars
Investing activities
negative 287,800,000 US dollars. Net cash used.
Capital expenditures
negative 126,000,000 US dollars
Investments in other assets
negative 164,600,000 US dollars
Proceeds from capital-related government incentives
400,000 US dollars
Other investing
2,400,000 US dollars
Financing activities
negative 158,300,000 US dollars. Net cash used.
Proceeds from borrowings on Revolving Credit Facility
68,000,000 US dollars
Proceeds from sale of common stock
65,400,000 US dollars
Repurchase of common stock
negative 96,500,000 US dollars
Proceeds from borrowings on Revolving Credit Facility
negative 68,000,000 US dollars
Proceeds from issuance of Commercial Paper
13,937,500,000 US dollars
Repayment of senior notes
negative 1,000,000,000 US dollars
Repayments of Commercial Paper
negative 15,113,900,000 US dollars
Payments on settlement of convertible debt
negative 672,200,000 US dollars
Capital lease payments
negative 1,600,000 US dollars
Tax payments related to shares withheld for vested RSUs
negative 57,600,000 US dollars
Payment of cash dividends
negative 975,700,000 US dollars
Proceeds from issuance of convertible debt
1,250,000,000 US dollars
Deferred financing costs
negative 19,700,000 US dollars
Purchase of capped call options
negative 160,100,000 US dollars
Proceeds from borrowings on 2025 Term Loan Facility
0 US dollars
Proceeds from issuance of senior notes
1,992,200,000 US dollars
Other Financing
negative 5,600,000 US dollars
Repayments of 2025 Term Loan Facility
negative 750,000,000 US dollars
Issuance of Series A Preferred Stock
1,449,500,000 US dollars
Operating adjustment reconciliation
1,490,400,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
18,920,900,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
290,600,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Mar 31, 2025
771,700,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
1,217,800,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
452,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
898,100,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
126,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
772,100,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$500.00K + net operating adjustments $898.60M = operating cash +$898.10M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 898,100,000 US dollars minus 126,000,000 US dollars equals 772,100,000 US dollars.
MICROCHIP TECHNOLOGY INCORPORATED (MCHP) FY2025 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!